Anemia, Sickle Cell

Descriptive text is not available for this image BASICS

DESCRIPTION

  • Hereditary, hemoglobinopathy marked by chronic hemolytic anemia, acute episodes of painful crises, and increased susceptibility to infections
  • The heterozygous condition (Hb AS), sickle cell trait, is usually asymptomatic without anemia.
  • Synonym(s): sickle cell disease (SCD); Hb SS disease

EPIDEMIOLOGY

Prevalence

  • ~100,000 Americans have sickle cell anemia (SCA), and ~3 million people in the United States have sickle cell trait.
  • The condition affects mainly people of African descent. Hispanic, Middle Eastern, Asian Indian, and Mediterranean ancestry may also be affected.

ETIOLOGY AND PATHOPHYSIOLOGY

  • Hemoglobin S (HbS) results from the substitution of the amino acid valine for glutamic acid at the sixth position of the β-globin chain.
  • HbS polymerization occurs in the RBC with increased concentrations of HbS and in deoxygenated states, resulting in RBC sickling.
  • Sickle RBCs exhibit increased adhesion, are inflexible, and have decreased ability to maneuver through small vessels leading to increased blood viscosity, stasis, and vaso-occlusion of small arterioles and capillaries, resulting in ischemia.
  • Sickle cell crises:
    • Vaso-occlusive crisis: tissue ischemia and necrosis; progressive organ failure/tissue damage from repeated episodes
    • Aplastic crisis: suppression of RBC production by severe infection (e.g., parvovirus and other viral infections)
    • Hyperhemolytic crisis: accelerated hemolysis with reticulocytosis; increased RBC fragility/shortened lifespan
    • Sequestration crisis: splenic sequestration of blood (only in young children as spleen is later lost to autoinfarction)
  • Hand–foot syndrome: Vessel occlusion/ischemia affects small blood vessels in hands or feet.

Genetics

  • Autosomal recessive; homozygous condition, HbSS; heterozygous condition, HbAS
  • The heterozygous condition can also be combined with other hemoglobinopathies: Sickle cell hemoglobin C (HbSC) disease and Sβ + thalassemia are clinically similar to the heterozygous condition, whereas Sβ thalassemia is clinically similar to the homozygous condition.

RISK FACTORS

  • Vaso-occlusive crisis: hypoxia, dehydration, high altitudes, stress, fever, infection, acidosis, cold, anesthesia, strenuous physical exercise, alcohol, smoking
  • Aplastic crisis: severe infections, human parvovirus B19 infection, folic acid deficiency
  • Hyperhemolytic crisis: acute bacterial infections, exposure to oxidant

GENERAL PREVENTION

  • Prevention of crises
    • Avoid hypoxia, dehydration, cold, infection, fever, acidosis, and anesthesia.
    • Prompt management of fever, infections, pain
    • Avoid alcohol and smoking. Avoid high-altitude areas.
  • Minimizing trauma: Aseptic technique is imperative.

There's more to see -- the rest of this topic is available only to subscribers.